Bay Harbor Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.7K Sell
1,562
-34
-2% -$1.85K 0.02% 133
2026
Q1
$100K Buy
1,596
+1,513
+1,823% +$121K 0.03% 91
2025
Q4
$7.91K Buy
83
+31
+60% +$3.04K ﹤0.01% 208
2025
Q3
$5.08K Sell
52
-921
-95% -$95.4K ﹤0.01% 203
2025
Q2
$105K Sell
973
-155
-14% -$15.7K 0.03% 78
2025
Q1
$114K Buy
1,128
+12
+1% +$1.21K 0.04% 62
2024
Q4
$99.7K Buy
1,116
+20
+2% +$1.76K 0.03% 72
2024
Q3
$91.8K Sell
1,096
-41
-4% -$3.23K 0.03% 69
2024
Q2
$87.6K Buy
1,137
+243
+27% +$17.8K 0.03% 72
2024
Q1
$61.2K Sell
894
-11
-1% -$707 0.02% 100
2023
Q4
$52.3K Buy
905
+7
+0.8% +$374 0.02% 101
2023
Q3
$47.4K Buy
898
+15
+2% +$787 0.02% 97
2023
Q2
$47.8K Sell
883
-64
-7% -$3.34K 0.02% 96
2023
Q1
$47.4K Buy
+947
New +$44.6K 0.02% 94

Other funds holding BSX

Bay Harbor Wealth Management's BSX Position: Q2 2026 in Review

Bay Harbor Wealth Management reduced its Boston Scientific (BSX) stake by 2.1% in Q2 2026, selling an estimated $1.85K and leaving 1,562 shares worth $66.7K. The position accounts for 0.02% of the portfolio, ranked #133.

Bay Harbor Wealth Management first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $114K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bay Harbor Wealth Management held 1,562 shares of Boston Scientific worth $66.7K as of Q2 2026.
  • Bay Harbor Wealth Management sold 34 Boston Scientific shares in Q2 2026, an estimated $1.85K.
  • Boston Scientific made up 0.02% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #133 holding.
  • Bay Harbor Wealth Management first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Bay Harbor Wealth Management's Boston Scientific position peaked at $114K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.